Apotex to donate 240,000 doses of anti-malaria drug for COVID-19 trial
-blueskygg(Grass);
2020-3-22{872}(#12788023@0)
Apotex Inc. is donating about 240,000 doses of a drug normally used to treat malaria for a study aimed at preventing COVID-19 infection in front-line medical staff, the company said.